Congress funds sickle cell surveillance, restores CDC workforce cuts
H.R. 8067 — Candis King Hope for Sickle Cell Families Act · Filed by Eugene Vindman (D-VA) · Introduced Mar 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the CDC to collect comprehensive data on sickle cell disease in the United States through grants to states, and requires the HHS Secretary to reinstate employees of the CDC's Division of Blood Disorders and Public Health Genomics who were removed in mass layoffs (3% or more within 60 days) after January 1, 2025. The bill authorizes $10 million annually for five years (2027–2031) for the data collection program.
Why we flagged it
The bill's operative mechanism is twofold: establishing a CDC surveillance program for sickle cell disease (a public health data initiative) and mandating reinstatement of federal health workers removed in recent reductions. Both are public health infrastructure measures, not regulatory or market-facing.
What the text implies
- The reinstatement mandate targets employees removed after January 1, 2025, suggesting a response to recent CDC workforce reductions; this implicitly signals concern about ongoing or recent agency restructuring.
- Sickle cell disease surveillance data may inform future treatment access, insurance coverage, and clinical trial recruitment — outcomes that depend on how states and CDC use the collected data.
- The bill names the program after Candis King, a sickle cell advocate; the legislative framing centers a patient/family perspective on disease burden, which may increase political salience for future sickle cell policy.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds public health surveillance of a disease disproportionately affecting Black Americans, improving data for treatment and policy; it also protects federal public health workers from mass layoffs, preserving institutional capacity. Both mechanisms serve the broad public interest in disease understanding and health system stability.
Who stands to gain
- state health departments (grant recipients)
- CDC Division of Blood Disorders and Public Health Genomics (restored funding and workforce)
Named in the bill
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), Division of Blood Disorders and Public Health Genomics, state health departments
Where it stands
- Mar 24, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 24, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,300 characters) on Sep 23, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 14,784 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-09-24.
“Congress funds sickle cell surveillance, restores CDC workforce cuts” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8067 Report an error